True Wealth Design’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.8K Buy
240
+157
+189% +$32.5K 0.01% 512
2026
Q1
$18.6K Buy
83
+39
+89% +$9.72K 0.01% 745
2025
Q4
$10.6K Sell
44
-40
-48% -$10.2K ﹤0.01% 843
2025
Q3
$22.9K Buy
84
+33
+65% +$9.01K 0.01% 557
2025
Q2
$13.1K Buy
51
+2
+4% +$477 ﹤0.01% 486
2025
Q1
$10.9K Sell
49
-206
-81% -$48.1K ﹤0.01% 450
2024
Q4
$58.2K Buy
255
+140
+122% +$33.7K 0.02% 139
2024
Q3
$28.1K Buy
115
+110
+2,200% +$24.6K 0.01% 265
2024
Q2
$958 Buy
5
+2
+67% +$406 ﹤0.01% 515
2024
Q1
$595 Buy
3
+1
+50% +$183 ﹤0.01% 592
2023
Q4
$345 Hold
2
﹤0.01% 580
2023
Q3
$296 Hold
2
﹤0.01% 564
2023
Q2
$437 Hold
2
﹤0.01% 481
2023
Q1
$438 Hold
2
﹤0.01% 557
2022
Q4
$416 Buy
+2
New +$439 ﹤0.01% 501

Other funds holding RMD

True Wealth Design's RMD Position: Q2 2026 in Review

True Wealth Design increased its ResMed (RMD) stake by 189% in Q2 2026, buying an estimated $32.5K and bringing the position to 240 shares worth $46.8K. The position accounts for 0.01% of the portfolio, ranked #512.

True Wealth Design first reported a position in RMD in Q4 2022 and has held it in 15 quarters since. The position peaked at $58.2K in Q4 2024. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • True Wealth Design held 240 shares of ResMed worth $46.8K as of Q2 2026.
  • True Wealth Design bought 157 ResMed shares in Q2 2026, an estimated $32.5K.
  • ResMed made up 0.01% of True Wealth Design's portfolio in Q2 2026, its #512 holding.
  • True Wealth Design first reported a position in ResMed in Q4 2022 and has held it in 15 quarters since.
  • True Wealth Design's ResMed position peaked at $58.2K in Q4 2024.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.